Growth inhibition of hepatocellular carcinoma by the polysaccharide-protein complex from Inonotus hispidus mycelia and the mechanisms.

BACKGROUND

Polysaccharide-protein (PSP) complexes derived from edible fungi are promising candidates against tumors, offering substantial efficacy with minimal side effects. This study aimed to isolate a PSP from the cultivated mycelia of the edible fungus Inonotus hispidus and evaluate its antitumor potential.

RESULTS

Through activity-guided fractionation, a highly active fraction, PSP-1, was attained and characterized as a PSP complex containing 644.8 g kg-1 total sugar and 288.9 g kg-1 protein, with an average molecular weight of 327 kDa. The polysaccharide portion of PSP-1 was composed of glucose, mannose, galactose, and fucose at a molar ratio of 4.90:2.55:3.35:1.00, and the protein part was composed dominantly of glutamic acid, methionine, and aspartic acid. In vivo, PSP-1 showed a significant tumor inhibition rate of 36.9 ± 2.3% at a low dose of 100 mg kg-1 in a hepatocellular carcinoma model and doubled the antitumor efficacy of cyclophosphamide. In HepG2 cancer cell culture, PSP-1 significantly inhibited cell proliferation with an half-maximal inhibitory concentration (IC50) value of 87.9 μg mL-1. PSP-1 induced apoptosis via cell cycle arrest through a mitochondria-mediated Caspase-dependent pathway.

CONCLUSION

The findings suggest that the I. hispidus mycelium-derived PSP complex is a promising component in functional foods to prevent the occurrence and inhibit the development of liver tumors, either alone or in combination with chemotherapy drugs. © 2026 Society of Chemical Industry.